IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
IQVIA Holdings (NYSE:IQV) has announced that Ron Bruehlman, executive vice president and chief financial officer, will be presenting at the TD Cowen Annual Health Care Conference. The presentation is scheduled for Tuesday, March 4, 2025, at 11:10 a.m. ET.
Investors and interested parties can access a live audio webcast of the presentation through IQVIA's Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be made available following the presentation on the same day.
IQVIA Holdings (NYSE:IQV) ha annunciato che Ron Bruehlman, vicepresidente esecutivo e direttore finanziario, presenterà alla Conferenza Annuale sulla Salute di TD Cowen. La presentazione è programmata per martedì 4 marzo 2025, alle 11:10 ET.
Gli investitori e le parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web delle Relazioni con gli Investitori di IQVIA all'indirizzo http://ir.iqvia.com. Una registrazione del webcast sarà disponibile dopo la presentazione nello stesso giorno.
IQVIA Holdings (NYSE:IQV) ha anunciado que Ron Bruehlman, vicepresidente ejecutivo y director financiero, presentará en la Conferencia Anual de Salud de TD Cowen. La presentación está programada para el martes 4 de marzo de 2025, a las 11:10 a.m. ET.
Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de Relaciones con Inversores de IQVIA en http://ir.iqvia.com. Una repetición del webcast estará disponible después de la presentación el mismo día.
IQVIA Holdings (NYSE:IQV)는 Ron Bruehlman 부사장 겸 최고 재무 책임자가 TD Cowen 연례 건강 관리 컨퍼런스에서 발표할 것이라고 발표했습니다. 발표는 2025년 3월 4일 화요일 오전 11:10 ET로 예정되어 있습니다.
투자자 및 이해관계자는 IQVIA의 투자자 관계 웹사이트(http://ir.iqvia.com)를 통해 발표의 실시간 오디오 웹캐스트에 접근할 수 있습니다. 발표 후 같은 날 웹캐스트의 재생이 제공될 예정입니다.
IQVIA Holdings (NYSE:IQV) a annoncé que Ron Bruehlman, vice-président exécutif et directeur financier, présentera lors de la Conférence Annuelle sur la Santé de TD Cowen. La présentation est prévue pour mardi 4 mars 2025, à 11h10 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de la présentation via le site web des Relations avec les Investisseurs d'IQVIA à l'adresse http://ir.iqvia.com. Un enregistrement du webcast sera disponible après la présentation le même jour.
IQVIA Holdings (NYSE:IQV) hat angekündigt, dass Ron Bruehlman, Executive Vice President und Chief Financial Officer, auf der TD Cowen Jahreskonferenz zur Gesundheitsversorgung präsentieren wird. Die Präsentation ist für Dienstag, den 4. März 2025, um 11:10 Uhr ET angesetzt.
Investoren und Interessierte können über die Investor Relations-Website von IQVIA auf ein Live-Audio-Webcast der Präsentation zugreifen unter http://ir.iqvia.com. Eine Wiederholung des Webcasts wird am selben Tag nach der Präsentation verfügbar sein.
- None.
- None.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250220975332/en/
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)
+1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin@iqvia.com)
+1.919.923.6785
Source: IQVIA
FAQ
When is Ron Bruehlman speaking at the TD Cowen Health Care Conference for IQVIA (IQV)?
How can investors watch IQVIA's (IQV) presentation at the TD Cowen conference?
Will there be a replay available of IQVIA's (IQV) TD Cowen conference presentation?
What is Ron Bruehlman's role at IQVIA (IQV)?
